Financhill
Buy
59

BEKE Quote, Financials, Valuation and Earnings

Last price:
$18.39
Seasonality move :
-1.03%
Day range:
$17.89 - $18.56
52-week range:
$12.44 - $26.05
Dividend yield:
1.91%
P/E ratio:
37.28x
P/S ratio:
2.01x
P/B ratio:
2.19x
Volume:
5.1M
Avg. volume:
8M
1-year change:
22.05%
Market cap:
$22.1B
Revenue:
$11B
EPS (TTM):
$0.49
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $6.7B $10.2B $12.5B $9B $11B
Revenue Growth (YoY) 53.73% 53.31% 22.46% -27.78% 21.74%
 
Cost of Revenues $5B $7.8B $10.1B $7B $7.9B
Gross Profit $1.6B $2.4B $2.5B $2.1B $3.1B
Gross Profit Margin 24.49% 23.92% 19.59% 22.72% 27.92%
 
R&D Expenses $227.5M $359.1M $494.7M $379M $273.8M
Selling, General & Admin $1.7B $1.6B $2B $1.8B $2.1B
Other Inc / (Exp) -$9.5M $39M $51.8M -$64.7M $136.9M
Operating Expenses $1.8B $1.9B $2.4B $2.1B $2.3B
Operating Income -$208.6M $573M $70M -$2.5M $799.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$184.7M $635.7M $176.7M $43.5M $1.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $130.9M $233.1M $258M $251.5M $281.9M
Net Income to Company -$315.6M $402.6M -$81.3M -$208M $832.6M
 
Minority Interest in Earnings -$495K -$105.9K $98.7K $1.7M -$902K
Net Income to Common Excl Extra Items -$316.1M $402.5M -$81.2M -$206.4M $831.7M
 
Basic EPS (Cont. Ops) -$0.49 $0.14 -$0.07 -$0.17 $0.71
Diluted EPS (Cont. Ops) -$0.49 $0.14 -$0.07 -$0.17 $0.69
Weighted Average Basic Share $1.2B $742.1M $1.2B $1.2B $1.2B
Weighted Average Diluted Share $1.2B $755.8M $1.2B $1.2B $1.2B
 
EBITDA -$8M $833.1M $390.8M $269.4M $1.3B
EBIT -$158.5M $663M $178.5M $45.7M $1.1B
 
Revenue (Reported) $6.7B $10.2B $12.5B $9B $11B
Operating Income (Reported) -$208.6M $573M $70M -$2.5M $799.1M
Operating Income (Adjusted) -$158.5M $663M $178.5M $45.7M $1.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $3B $2.8B $2.6B $2.5B $3.2B
Revenue Growth (YoY) 73.2% -5.85% -8.07% -4.19% 28.16%
 
Cost of Revenues $2.3B $2.4B $1.9B $1.8B $2.4B
Gross Profit $633M $425.3M $694.8M $674.5M $717.1M
Gross Profit Margin 21.33% 15.22% 27.05% 27.41% 22.74%
 
R&D Expenses $114M $161M $74.3M $65.2M $80M
Selling, General & Admin $530.8M $558.1M $443M $482.7M $535.6M
Other Inc / (Exp) $56.8M $38.6M -$40.1M $56.1M $88.6M
Operating Expenses $644.7M $719.2M $517.3M $547.9M $615.6M
Operating Income -$11.7M -$293.8M $177.5M $126.6M $101.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $48.3M -$241.2M $168.7M $231M $233.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $37.4M $31.4M $64.2M $69.3M $70.3M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$93K -- -- -$1.7M $372.5K
Net Income to Common Excl Extra Items $10.8M -$272.7M $104.5M $160M $163.6M
 
Basic EPS (Cont. Ops) -$0.05 -$0.23 $0.09 $0.14 $0.15
Diluted EPS (Cont. Ops) -$0.05 -$0.23 $0.09 $0.13 $0.14
Weighted Average Basic Share $823.4M $1.2B $1.2B $1.2B $1.1B
Weighted Average Diluted Share $823.4M $1.2B $1.2B $1.2B $1.2B
 
EBITDA -$11.7M -$293.8M $177.5M $126.6M $101.5M
EBIT -$11.7M -$293.8M $177.5M $126.6M $101.5M
 
Revenue (Reported) $3B $2.8B $2.6B $2.5B $3.2B
Operating Income (Reported) -$11.7M -$293.8M $177.5M $126.6M $101.5M
Operating Income (Adjusted) -$11.7M -$293.8M $177.5M $126.6M $101.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $8.9B $13.1B $9.4B $10.6B $10.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.9B $10.3B $7.5B $7.6B $8.6B
Gross Profit $2B $2.8B $1.9B $2.9B $2.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $320.2M $487.1M $425.3M $271.2M $289.6M
Selling, General & Admin $1.9B $2.1B $1.8B $1.9B $2.3B
Other Inc / (Exp) $63.4M $120.4M -$161.2M $112.8M $181.3M
Operating Expenses $2.2B $2.4B $2.1B $2.1B $2.4B
Operating Income -$176.2M $393.9M -$149.8M $879.2M $477.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$81.3M $552.2M -$219.9M $1.2B $838.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $127M $323.8M $201.1M $361.8M $257.9M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$7.8K -$662.3K -$134K -$799.9K -$899.7K
Net Income to Common Excl Extra Items -$208.3M $227.7M -$421M $801.9M $580M
 
Basic EPS (Cont. Ops) -$0.59 $0.20 -$0.35 $0.68 $0.51
Diluted EPS (Cont. Ops) -$0.59 $0.19 -$0.35 $0.66 $0.49
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$127M $487.6M -$40.3M $924.6M $790.6M
EBIT -$127M $487.6M -$40.3M $924.6M $790.6M
 
Revenue (Reported) $8.9B $13.1B $9.4B $10.6B $10.8B
Operating Income (Reported) -$176.2M $393.9M -$149.8M $879.2M $477.9M
Operating Income (Adjusted) -$127M $487.6M -$40.3M $924.6M $790.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $6.8B $9.7B $6.6B $8.2B $8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.2B $7.7B $5.2B $5.8B $6.5B
Gross Profit $1.6B $2B $1.5B $2.4B $2.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $252.4M $379.3M $310M $199.7M $215.5M
Selling, General & Admin $1.2B $1.6B $1.3B $1.4B $1.6B
Other Inc / (Exp) $120.3M $206.6M -$4.5M $166.3M $208.3M
Operating Expenses $1.4B $2B $1.6B $1.6B $1.8B
Operating Income $218.2M $35M -$185.1M $720.7M $388.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $361.2M $278.9M -$116.2M $1B $733M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $126.3M $215.7M $159M $273.1M $245.2M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$17.6K -$575K -$134K -$799.9K -$836.1K
Net Income to Common Excl Extra Items $234.8M $62.6M -$275.3M $748.1M $487M
 
Basic EPS (Cont. Ops) -$0.15 $0.06 -$0.23 $0.63 $0.43
Diluted EPS (Cont. Ops) -$0.15 $0.05 -$0.23 $0.62 $0.41
Weighted Average Basic Share $3.1B $3.5B $3.6B $3.5B $3.4B
Weighted Average Diluted Share $3.1B $3.6B $3.6B $3.6B $3.5B
 
EBITDA $218.2M $35M -$185.1M $720.7M $388.4M
EBIT $218.2M $35M -$185.1M $720.7M $388.4M
 
Revenue (Reported) $6.8B $9.7B $6.6B $8.2B $8B
Operating Income (Reported) $218.2M $35M -$185.1M $720.7M $388.4M
Operating Income (Adjusted) $218.2M $35M -$185.1M $720.7M $388.4M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $3.5B $6.3B $3.2B $2.8B $2.8B
Short Term Investments $263.6M $2.4B $4.6B $5.1B $4.8B
Accounts Receivable, Net $1.2B $2B $1.5B $590.7M $425.7M
Inventory -- -- $3M $18.5M $42.9M
Prepaid Expenses $607.9M $565.4M $304.1M $372.4M $375.9M
Other Current Assets $45.5M $42.3M $56.4M $72.5M $89M
Total Current Assets $7.4B $13.4B $11B $10.2B $9.8B
 
Property Plant And Equipment $962.1M $1.3B $1.4B $1.9B $2.8B
Long-Term Investments $333.5M $480.7M $2.7B $2.6B $3.3B
Goodwill $354M $377.7M $283.3M $715.2M $685.2M
Other Intangibles $369.9M $255.6M $183.2M $256.9M $184.1M
Other Long-Term Assets $41.5M $16.8M $19M $784.7K $1.7M
Total Assets $9.6B $16B $15.7B $15.8B $17B
 
Accounts Payable $576.4M $986.1M $900.4M $846.9M $892.8M
Accrued Expenses -- -- -- $31.2M $41.2M
Current Portion Of Long-Term Debt $327.5M $231.5M $30.5M -- --
Current Portion Of Capital Lease Obligations $317.7M $401.9M $431.9M $720.7M $1.3B
Other Current Liabilities $193.6M $293.4M $393.7M $500.6M $681.9M
Total Current Liabilities $4B $5.1B $4.5B $4.8B $5.6B
 
Long-Term Debt $700M $2.3M -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $5.1B $5.7B $5.2B $5.8B $6.8B
 
Common Stock $5.8B $73.8K $76.7K $70.6K $67K
Other Common Equity Adj $45.3M -$220.6M -$338.2M $36M $148.9M
Common Equity -$1.3B $10.2B $10.5B $10B $10.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $12.5M $4.1M $12.8M $19.4M $14.3M
Total Equity $4.5B $10.2B $10.5B $10B $10.2B
 
Total Liabilities and Equity $9.6B $16B $15.7B $15.8B $17B
Cash and Short Terms $3.7B $8.7B $7.8B $8B $7.6B
Total Debt $1.1B $233.8M $71.3M $89.7M $41M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $5.6B $3.4B $2.7B $2.2B $1.4B
Short Term Investments $1.9B $3.6B $4.6B $5.3B $6.2B
Accounts Receivable, Net $1.6B $1.6B $687.5M $379.8M $467.4M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $11.1B $10.9B $9.4B $9.5B $9.9B
 
Property Plant And Equipment $1.1B $1.5B $1.7B $2.5B $3.5B
Long-Term Investments $360.6M $2.7B $2.9B $3.3B $3.1B
Goodwill $364.8M $325.7M $701.9M $673.5M $690.1M
Other Intangibles $302.1M $197.8M $260.6M $168.2M $135.3M
Other Long-Term Assets $88.9M $152.2M $143.6M $142M $190.8M
Total Assets $13.3B $15.8B $15.2B $16.2B $17.5B
 
Accounts Payable $923.3M $820.5M $774.3M $753.2M $911.2M
Accrued Expenses $370.9M $407.1M $550.3M $827.6M $1B
Current Portion Of Long-Term Debt $436.7M $101.5M $84.2M $71.3M $43.7M
Current Portion Of Capital Lease Obligations $357.1M $445.7M $615.7M $1.1B $1.8B
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.6B $4.5B $4.5B $5.2B $6.2B
 
Long-Term Debt $690.5M -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $5.8B $5.3B $5.4B $6.4B $7.4B
 
Common Stock $68.3K $75.6K $69K $66.2K $66K
Other Common Equity Adj -$40.7M -$267M $60.1M $124.8M $155M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3.9M $8.2M $19M $14.8M $17M
Total Equity $7.5B $10.5B $9.7B $9.9B $10.1B
 
Total Liabilities and Equity $13.3B $15.8B $15.2B $16.2B $17.5B
Cash and Short Terms $7.5B $7B $7.3B $7.4B $7.6B
Total Debt $1.1B $101.5M $84.2M $71.3M $43.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$315.6M $402.6M -$81.3M -$208M $832.6M
Depreciation & Amoritzation $150.5M $170.1M $212.3M $223.7M $198.2M
Stock-Based Compensation $427.9M $326.4M $238.2M $361.1M $454.6M
Change in Accounts Receivable -$713.4M -$781.4M $393.2M $795.9M $116.1M
Change in Inventories -- -- -- -- --
Cash From Operations $16.3M $1.4B $556.8M $1.3B $1.6B
 
Capital Expenditures $101.8M $128.5M $221.5M $118.1M $123.6M
Cash Acquisitions -$107.7M $2M -$514.4K -$465.8M $699.1K
Cash From Investing -$560.8M -$2.2B -$3.9B -$1.3B -$562.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$201.6M
Special Dividend Paid
Long-Term Debt Issued $1.8B $514.8M $118.9M $132.9M $60.3M
Long-Term Debt Repaid -$782.6M -$1.4B -$285.1M -$108.3M -$106.9M
Repurchase of Common Stock -$399.8M -- -- -$196.5M -$728.1M
Other Financing Activities $427.5M -$35.6M -$134.8K -- -$7.9M
Cash From Financing $3.3B $3.7B -$166.4M -$171.9M -$984.2M
 
Beginning Cash (CF) $1.8B $4.6B $7.7B $4B $3.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.8B $2.9B -$3.5B -$173.7M $30.9M
Ending Cash (CF) $4.6B $7.2B $4.1B $3.8B $3.7B
 
Levered Free Cash Flow -$85.5M $1.2B $335.3M $1.1B $1.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $481.2M -$180.1M $272.6M $237M $65.1M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1B -$1.7B $622.2M -$2.2B -$76.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- $171K --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $2.4B $11.4M -$40.7M -$348.5M -$225.4M
 
Beginning Cash (CF) $4.8B $6.4B $2.9B $5.4B $2.4B
Foreign Exchange Rate Adjustment -$117.4M $13.2M -$23.5M $22.7M -$6.5M
Additions / Reductions $1.9B -$1.9B $854.1M -$2.3B -$237.1M
Ending Cash (CF) $6.7B $4.5B $3.6B $3B $2.2B
 
Levered Free Cash Flow $481.2M -$180.1M $272.6M $237M $65.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $427.9M $326.4M -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.1B $521.6M $1B $1.7B $881.5M
 
Capital Expenditures $101.8M $128.5M -- -- --
Cash Acquisitions -$107.7M $2.1M -- -- --
Cash From Investing -$1.7B -$4.1B -$1.6B -$1.2B -$527.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $5.1B $1.2B -$67.1M -$894.6M -$1.2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.5B -$2.4B -$667.8M -$417.2M -$845.7M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1B $521.6M $1B $1.7B $881.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.2B $357.6M $848.7M $1.3B $601.5M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.4B -$3.3B -$1.1B -$1.1B -$1B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- $171K --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $2.3B -$134.6M -$35.3M -$757.9M -$973M
 
Beginning Cash (CF) $12.5B $20.2B $10.8B $14.8B $9.5B
Foreign Exchange Rate Adjustment -$100.9M -$34M -$1.9M $25.8M -$2.1M
Additions / Reductions $2.1B -$3.1B -$279.6M -$523.2M -$1.4B
Ending Cash (CF) $14.6B $17.1B $10.2B $14.1B $8.1B
 
Levered Free Cash Flow $1.2B $357.6M $848.7M $1.3B $601.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock